Application deadline: December 1
Established in 2001, TPCB is a leading chemical biology PhD graduate program offered jointly by Weill Cornell Medicine, The Rockefeller University, and Memorial Sloan Kettering Cancer Center. The Tri-Institutional campus in the heart of New York City provides an exciting combination of outstanding faculty, state-of-the-art facilities, and collaborative research opportunities to the next generation of scientific leaders working at the interface of chemistry, biology, and medicine.
Students from underrepresented minority groups and disadvantaged backgrounds, and those with disabilities, are encouraged to apply. Fee waivers can be provided to any students for whom the fee would represent an obstacle to applying to TPCB.
Application deadline: December 1
Website: http://chembio.triiprograms.org
Fee waivers: Contact Margie Mendoza for info: mah2036@med.cornell.edu